Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine.

Gómez de la Torre, Juan C; Hueda-Zavaleta, Miguel; Cáceres-DelAguila, José Alonso; Muro-Rojo, Cecilia; Cruz-Escurra, Nathalia De La; Benítes-Zapata, Vicente A

Gómez de la Torre, Juan C; Hueda-Zavaleta, Miguel; Cáceres-DelAguila, José Alonso; Muro-Rojo, Cecilia; Cruz-Escurra, Nathalia De La; Benítes-Zapata, Vicente A.

Afiliação

Gómez de la Torre JC; Roe Clinical Laboratory, Dos de Mayo Avenue, 1741, San Isidro, Lima 15076, Peru.
Hueda-Zavaleta M; Hospital III Daniel Alcides Carrión, Essalud, Calana Road, Km 6.5, Calana, Tacna 23000, Peru.
Cáceres-DelAguila JA; Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Bolognesi Avenue Number 1177, Tacna 23003, Peru.
Muro-Rojo C; Roe Clinical Laboratory, Dos de Mayo Avenue, 1741, San Isidro, Lima 15076, Peru.
Cruz-Escurra N; Roe Clinical Laboratory, Dos de Mayo Avenue, 1741, San Isidro, Lima 15076, Peru.
Benítes-Zapata VA; Roe Clinical Laboratory, Dos de Mayo Avenue, 1741, San Isidro, Lima 15076, Peru.

Vaccines (Basel) ; 11(5)2023 Apr 25.

Article em En | MEDLINE | ID: mdl-37242998

Palavras-chave

COVID-19; SARS-CoV-2; heterologous booster vaccine; humoral immunity; neutralizing antibody; vaccine breakthrough infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google